▶ 調査レポート

バイオシミラーインスリンの世界市場 2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Biosimilar Insulin Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。バイオシミラーインスリンの世界市場 2020年:メーカー別、地域別、種類・用途別 / Global Biosimilar Insulin Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D005-03039資料のイメージです。• レポートコード:D005-03039
• 出版社/出版日:GlobalInfoResearch / 2020年5月
• レポート形態:英文、PDF、102ページ
• 納品方法:Eメール(納期2~3日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥393,240 (USD3,480)▷ お問い合わせ
  Multi User¥589,860 (USD5,220)▷ お問い合わせ
  Corporate User¥786,480 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、バイオシミラーインスリンの世界市場を広く調査・分析し、今後の市場展望をまとめております。バイオシミラーインスリンの種類別市場規模(速効型インスリン、速効型インスリン、中型インスリン、持続型インスリン)、用途別市場規模(病院、クリニック、医療センター)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Pfizer、Samsung Bioepis、Gan&Lee Pharmaceuticals、Biogenomics、Paras Biopharmaceuticals、Eli Lilly、Wockhardt、Julphar Gulf Pharmaceutical Industries、Geropharm、Sedico、Teva Pharmaceuticals
・地域別グローバル市場分析 2015年-2020年
・バイオシミラーインスリンの北米市場(アメリカ、カナダ、メキシコ)
・バイオシミラーインスリンのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・バイオシミラーインスリンのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・バイオシミラーインスリンの南米市場(ブラジル、アルゼンチン)
・バイオシミラーインスリンの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:速効型インスリン、速効型インスリン、中型インスリン、持続型インスリン
・用途別分析:病院、クリニック、医療センター
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Biosimilar Insulin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Biosimilar Insulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Biosimilar Insulin market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Biosimilar Insulin market has been segmented into
Rapid Acting Insulins
Short Acting Insulins
Intermediate Insulins
Long Lasting Insulins

By Application, Biosimilar Insulin has been segmented into:
Hospital
Clinic
Medical Center

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biosimilar Insulin market presented in the report. This section sheds light on the sales growth of different regional and country-level Biosimilar Insulin markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biosimilar Insulin market.

The report offers in-depth assessment of the growth and other aspects of the Biosimilar Insulin market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Biosimilar Insulin Market Share Analysis
Biosimilar Insulin competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biosimilar Insulin sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biosimilar Insulin sales, revenue and market share for each player covered in this report.

The major players covered in Biosimilar Insulin are:
Pfizer
Samsung Bioepis
Gan&Lee Pharmaceuticals
Biogenomics
Paras Biopharmaceuticals
Eli Lilly
Wockhardt
Julphar Gulf Pharmaceutical Industries
Geropharm
Sedico
Teva Pharmaceuticals

Among other players domestic and global, Biosimilar Insulin market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biosimilar Insulin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biosimilar Insulin, with price, sales, revenue and global market share of Biosimilar Insulin in 2018 and 2019.
Chapter 3, the Biosimilar Insulin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biosimilar Insulin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Biosimilar Insulin market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Biosimilar Insulin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Biosimilar Insulin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biosimilar Insulin Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Rapid Acting Insulins
1.2.3 Short Acting Insulins
1.2.4 Intermediate Insulins
1.2.5 Long Lasting Insulins
1.3 Market Analysis by Application
1.3.1 Overview: Global Biosimilar Insulin Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Medical Center
1.4 Overview of Global Biosimilar Insulin Market
1.4.1 Global Biosimilar Insulin Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Biosimilar Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Samsung Bioepis
2.2.1 Samsung Bioepis Details
2.2.2 Samsung Bioepis Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Samsung Bioepis SWOT Analysis
2.2.4 Samsung Bioepis Product and Services
2.2.5 Samsung Bioepis Biosimilar Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Gan&Lee Pharmaceuticals
2.3.1 Gan&Lee Pharmaceuticals Details
2.3.2 Gan&Lee Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Gan&Lee Pharmaceuticals SWOT Analysis
2.3.4 Gan&Lee Pharmaceuticals Product and Services
2.3.5 Gan&Lee Pharmaceuticals Biosimilar Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Biogenomics
2.4.1 Biogenomics Details
2.4.2 Biogenomics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Biogenomics SWOT Analysis
2.4.4 Biogenomics Product and Services
2.4.5 Biogenomics Biosimilar Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Paras Biopharmaceuticals
2.5.1 Paras Biopharmaceuticals Details
2.5.2 Paras Biopharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Paras Biopharmaceuticals SWOT Analysis
2.5.4 Paras Biopharmaceuticals Product and Services
2.5.5 Paras Biopharmaceuticals Biosimilar Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Eli Lilly SWOT Analysis
2.6.4 Eli Lilly Product and Services
2.6.5 Eli Lilly Biosimilar Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Wockhardt
2.7.1 Wockhardt Details
2.7.2 Wockhardt Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Wockhardt SWOT Analysis
2.7.4 Wockhardt Product and Services
2.7.5 Wockhardt Biosimilar Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Julphar Gulf Pharmaceutical Industries
2.8.1 Julphar Gulf Pharmaceutical Industries Details
2.8.2 Julphar Gulf Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Julphar Gulf Pharmaceutical Industries SWOT Analysis
2.8.4 Julphar Gulf Pharmaceutical Industries Product and Services
2.8.5 Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Geropharm
2.9.1 Geropharm Details
2.9.2 Geropharm Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Geropharm SWOT Analysis
2.9.4 Geropharm Product and Services
2.9.5 Geropharm Biosimilar Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sedico
2.10.1 Sedico Details
2.10.2 Sedico Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sedico SWOT Analysis
2.10.4 Sedico Product and Services
2.10.5 Sedico Biosimilar Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Teva Pharmaceuticals
2.11.1 Teva Pharmaceuticals Details
2.11.2 Teva Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Teva Pharmaceuticals SWOT Analysis
2.11.4 Teva Pharmaceuticals Product and Services
2.11.5 Teva Pharmaceuticals Biosimilar Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Biosimilar Insulin Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Biosimilar Insulin Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Biosimilar Insulin Manufacturer Market Share in 2019
3.3.2 Top 6 Biosimilar Insulin Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Biosimilar Insulin Sales, Revenue and Market Share by Regions
4.1.1 Global Biosimilar Insulin Sales and Market Share by Regions (2015-2020)
4.1.2 Global Biosimilar Insulin Revenue and Market Share by Regions (2015-2020)
4.2 North America Biosimilar Insulin Sales and Growth Rate (2015-2020)
4.3 Europe Biosimilar Insulin Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Biosimilar Insulin Sales and Growth Rate (2015-2020)
4.5 South America Biosimilar Insulin Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Biosimilar Insulin Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Biosimilar Insulin Sales, Revenue and Market Share by Country
5.1.1 North America Biosimilar Insulin Sales and Market Share by Country (2015-2020)
5.1.2 North America Biosimilar Insulin Revenue and Market Share by Country (2015-2020)
5.2 United States Biosimilar Insulin Sales and Growth Rate (2015-2020)
5.3 Canada Biosimilar Insulin Sales and Growth Rate (2015-2020)
5.4 Mexico Biosimilar Insulin Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Biosimilar Insulin Sales, Revenue and Market Share by Country
6.1.1 Europe Biosimilar Insulin Sales and Market Share by Country (2015-2020)
6.1.2 Europe Biosimilar Insulin Revenue and Market Share by Country (2015-2020)
6.2 Germany Biosimilar Insulin Sales and Growth Rate (2015-2020)
6.3 UK Biosimilar Insulin Sales and Growth Rate (2015-2020)
6.4 France Biosimilar Insulin Sales and Growth Rate (2015-2020)
6.5 Russia Biosimilar Insulin Sales and Growth Rate (2015-2020)
6.6 Italy Biosimilar Insulin Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Biosimilar Insulin Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Biosimilar Insulin Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Biosimilar Insulin Revenue and Market Share by Regions (2015-2020)
7.2 China Biosimilar Insulin Sales and Growth Rate (2015-2020)
7.3 Japan Biosimilar Insulin Sales and Growth Rate (2015-2020)
7.4 Korea Biosimilar Insulin Sales and Growth Rate (2015-2020)
7.5 India Biosimilar Insulin Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Biosimilar Insulin Sales and Growth Rate (2015-2020)
7.7 Australia Biosimilar Insulin Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Biosimilar Insulin Sales, Revenue and Market Share by Country
8.1.1 South America Biosimilar Insulin Sales and Market Share by Country (2015-2020)
8.1.2 South America Biosimilar Insulin Revenue and Market Share by Country (2015-2020)
8.2 Brazil Biosimilar Insulin Sales and Growth Rate (2015-2020)
8.3 Argentina Biosimilar Insulin Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Biosimilar Insulin Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Biosimilar Insulin Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Biosimilar Insulin Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Biosimilar Insulin Sales and Growth Rate (2015-2020)
9.3 Turkey Biosimilar Insulin Sales and Growth Rate (2015-2020)
9.4 Egypt Biosimilar Insulin Sales and Growth Rate (2015-2020)
9.5 South Africa Biosimilar Insulin Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Biosimilar Insulin Sales and Market Share by Type (2015-2020)
10.2 Global Biosimilar Insulin Revenue and Market Share by Type (2015-2020)
10.3 Global Biosimilar Insulin Price by Type (2015-2020)
11 Global Biosimilar Insulin Market Segment by Application
11.1 Global Biosimilar Insulin Sales Market Share by Application (2015-2020)
11.2 Global Biosimilar Insulin Revenue Market Share by Application (2015-2020)
11.3 Global Biosimilar Insulin Price by Application (2015-2020)
12 Market Forecast
12.1 Global Biosimilar Insulin Sales, Revenue and Growth Rate (2021-2025)
12.2 Biosimilar Insulin Market Forecast by Regions (2021-2025)
12.2.1 North America Biosimilar Insulin Market Forecast (2021-2025)
12.2.2 Europe Biosimilar Insulin Market Forecast (2021-2025)
12.2.3 Asia-Pacific Biosimilar Insulin Market Forecast (2021-2025)
12.2.4 South America Biosimilar Insulin Market Forecast (2021-2025)
12.2.5 Middle East & Africa Biosimilar Insulin Market Forecast (2021-2025)
12.3 Biosimilar Insulin Market Forecast by Type (2021-2025)
12.3.1 Global Biosimilar Insulin Sales Forecast by Type (2021-2025)
12.3.2 Global Biosimilar Insulin Market Share Forecast by Type (2021-2025)
12.4 Biosimilar Insulin Market Forecast by Application (2021-2025)
12.4.1 Global Biosimilar Insulin Sales Forecast by Application (2021-2025)
12.4.2 Global Biosimilar Insulin Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Biosimilar Insulin Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biosimilar Insulin by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biosimilar Insulin Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Biosimilar Insulin Major Business
Table 9. Pfizer Biosimilar Insulin Total Revenue (USD Million) (2018-2019)
Table 10. Pfizer SWOT Analysis
Table 11. Pfizer Biosimilar Insulin Product and Services
Table 12. Pfizer Biosimilar Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Samsung Bioepis Basic Information, Manufacturing Base and Competitors
Table 14. Samsung Bioepis Biosimilar Insulin Major Business
Table 15. Samsung Bioepis Biosimilar Insulin Total Revenue (USD Million) (2018-2019)
Table 16. Samsung Bioepis SWOT Analysis
Table 17. Samsung Bioepis Biosimilar Insulin Product and Services
Table 18. Samsung Bioepis Biosimilar Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Gan&Lee Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Gan&Lee Pharmaceuticals Biosimilar Insulin Major Business
Table 21. Gan&Lee Pharmaceuticals Biosimilar Insulin Total Revenue (USD Million) (2018-2019)
Table 22. Gan&Lee Pharmaceuticals SWOT Analysis
Table 23. Gan&Lee Pharmaceuticals Biosimilar Insulin Product and Services
Table 24. Gan&Lee Pharmaceuticals Biosimilar Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Biogenomics Basic Information, Manufacturing Base and Competitors
Table 26. Biogenomics Biosimilar Insulin Major Business
Table 27. Biogenomics Biosimilar Insulin Total Revenue (USD Million) (2018-2019)
Table 28. Biogenomics SWOT Analysis
Table 29. Biogenomics Biosimilar Insulin Product and Services
Table 30. Biogenomics Biosimilar Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Paras Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Paras Biopharmaceuticals Biosimilar Insulin Major Business
Table 33. Paras Biopharmaceuticals Biosimilar Insulin Total Revenue (USD Million) (2018-2019)
Table 34. Paras Biopharmaceuticals SWOT Analysis
Table 35. Paras Biopharmaceuticals Biosimilar Insulin Product and Services
Table 36. Paras Biopharmaceuticals Biosimilar Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 38. Eli Lilly Biosimilar Insulin Major Business
Table 39. Eli Lilly Biosimilar Insulin Total Revenue (USD Million) (2018-2019)
Table 40. Eli Lilly SWOT Analysis
Table 41. Eli Lilly Biosimilar Insulin Product and Services
Table 42. Eli Lilly Biosimilar Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 44. Wockhardt Biosimilar Insulin Major Business
Table 45. Wockhardt Biosimilar Insulin Total Revenue (USD Million) (2018-2019)
Table 46. Wockhardt SWOT Analysis
Table 47. Wockhardt Biosimilar Insulin Product and Services
Table 48. Wockhardt Biosimilar Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Julphar Gulf Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 50. Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Major Business
Table 51. Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Total Revenue (USD Million) (2018-2019)
Table 52. Julphar Gulf Pharmaceutical Industries SWOT Analysis
Table 53. Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Product and Services
Table 54. Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Geropharm Basic Information, Manufacturing Base and Competitors
Table 56. Geropharm Biosimilar Insulin Major Business
Table 57. Geropharm Biosimilar Insulin Total Revenue (USD Million) (2018-2019)
Table 58. Geropharm SWOT Analysis
Table 59. Geropharm Biosimilar Insulin Product and Services
Table 60. Geropharm Biosimilar Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Sedico Basic Information, Manufacturing Base and Competitors
Table 62. Sedico Biosimilar Insulin Major Business
Table 63. Sedico Biosimilar Insulin Total Revenue (USD Million) (2018-2019)
Table 64. Sedico SWOT Analysis
Table 65. Sedico Biosimilar Insulin Product and Services
Table 66. Sedico Biosimilar Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Teva Pharmaceuticals Biosimilar Insulin Major Business
Table 69. Teva Pharmaceuticals Biosimilar Insulin Total Revenue (USD Million) (2018-2019)
Table 70. Teva Pharmaceuticals SWOT Analysis
Table 71. Teva Pharmaceuticals Biosimilar Insulin Product and Services
Table 72. Teva Pharmaceuticals Biosimilar Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global Biosimilar Insulin Sales by Manufacturer (2018-2019) (K Pcs)
Table 74. Global Biosimilar Insulin Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global Biosimilar Insulin Sales by Regions (2015-2020) (K Pcs)
Table 76. Global Biosimilar Insulin Sales Market Share by Regions (2015-2020)
Table 77. Global Biosimilar Insulin Revenue by Regions (2015-2020) (USD Million)
Table 78. North America Biosimilar Insulin Sales by Countries (2015-2020) (K Pcs)
Table 79. North America Biosimilar Insulin Sales Market Share by Countries (2015-2020)
Table 80. North America Biosimilar Insulin Revenue by Countries (2015-2020) (USD Million)
Table 81. North America Biosimilar Insulin Revenue Market Share by Countries (2015-2020)
Table 82. Europe Biosimilar Insulin Sales by Countries (2015-2020) (K Pcs)
Table 83. Europe Biosimilar Insulin Sales Market Share by Countries (2015-2020)
Table 84. Europe Biosimilar Insulin Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific Biosimilar Insulin Sales by Regions (2015-2020) (K Pcs)
Table 86. Asia-Pacific Biosimilar Insulin Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific Biosimilar Insulin Revenue by Regions (2015-2020) (USD Million)
Table 88. South America Biosimilar Insulin Sales by Countries (2015-2020) (K Pcs)
Table 89. South America Biosimilar Insulin Sales Market Share by Countries (2015-2020)
Table 90. South America Biosimilar Insulin Revenue by Countries (2015-2020) (USD Million)
Table 91. South America Biosimilar Insulin Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa Biosimilar Insulin Sales by Countries (2015-2020) (K Pcs)
Table 93. Middle East & Africa Biosimilar Insulin Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa Biosimilar Insulin Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa Biosimilar Insulin Revenue Market Share by Countries (2015-2020)
Table 96. Global Biosimilar Insulin Sales by Type (2015-2020) (K Pcs)
Table 97. Global Biosimilar Insulin Sales Share by Type (2015-2020)
Table 98. Global Biosimilar Insulin Revenue by Type (2015-2020) (USD Million)
Table 99. Global Biosimilar Insulin Revenue Share by Type (2015-2020)
Table 100. Global Biosimilar Insulin Sales by Application (2015-2020) (K Pcs)
Table 101. Global Biosimilar Insulin Sales Share by Application (2015-2020)
Table 102. Global Biosimilar Insulin Sales Forecast by Regions (2021-2025) (K Pcs)
Table 103. Global Biosimilar Insulin Market Share Forecast by Regions (2021-2025)
Table 104. Global Biosimilar Insulin Sales Forecast by Type (2021-2025) (K Pcs)
Table 105. Global Biosimilar Insulin Market Share Forecast by Type (2021-2025)
Table 106. Global Biosimilar Insulin Sales Forecast by Application (2021-2025)
Table 107. Global Biosimilar Insulin Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Biosimilar Insulin Picture
Figure 2. Global Sales Market Share of Biosimilar Insulin by Type in 2019
Figure 3. Rapid Acting Insulins Picture
Figure 4. Short Acting Insulins Picture
Figure 5. Intermediate Insulins Picture
Figure 6. Long Lasting Insulins Picture
Figure 7. Biosimilar Insulin Sales Market Share by Application in 2018
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Medical Center Picture
Figure 11. Global Biosimilar Insulin Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Biosimilar Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Biosimilar Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Biosimilar Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Biosimilar Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Biosimilar Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Biosimilar Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Biosimilar Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Biosimilar Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Biosimilar Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Biosimilar Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Biosimilar Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Biosimilar Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Biosimilar Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Biosimilar Insulin Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Biosimilar Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Biosimilar Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Biosimilar Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Biosimilar Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Biosimilar Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Biosimilar Insulin Sales Market Share by Manufacturer in 2019
Figure 32. Global Biosimilar Insulin Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Biosimilar Insulin Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Biosimilar Insulin Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Biosimilar Insulin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 37. Global Biosimilar Insulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Biosimilar Insulin Revenue Market Share by Regions (2015-2020)
Figure 39. Global Biosimilar Insulin Revenue Market Share by Regions in 2018
Figure 40. North America Biosimilar Insulin Sales and Growth Rate (2015-2020)
Figure 41. Europe Biosimilar Insulin Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Biosimilar Insulin Sales and Growth Rate (2015-2020)
Figure 43. South America Biosimilar Insulin Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Biosimilar Insulin Sales and Growth Rate (2015-2020)
Figure 45. North America Biosimilar Insulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Biosimilar Insulin Sales Market Share by Countries (2015-2020)
Figure 47. North America Biosimilar Insulin Sales Market Share by Countries in 2018
Figure 48. North America Biosimilar Insulin Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Biosimilar Insulin Revenue Market Share by Countries in 2018
Figure 50. United States Biosimilar Insulin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 51. Canada Biosimilar Insulin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Mexico Biosimilar Insulin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Europe Biosimilar Insulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Biosimilar Insulin Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Biosimilar Insulin Revenue Market Share by Countries in 2019
Figure 56. Germany Biosimilar Insulin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. UK Biosimilar Insulin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. France Biosimilar Insulin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. Russia Biosimilar Insulin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Italy Biosimilar Insulin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Asia-Pacific Biosimilar Insulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Biosimilar Insulin Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Biosimilar Insulin Revenue Market Share by Regions 2019
Figure 64. China Biosimilar Insulin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Biosimilar Insulin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Korea Biosimilar Insulin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. India Biosimilar Insulin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Southeast Asia Biosimilar Insulin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. South America Biosimilar Insulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Biosimilar Insulin Sales Market Share by Countries in 2019
Figure 71. South America Biosimilar Insulin Revenue Market Share by Countries in 2019
Figure 72. Brazil Biosimilar Insulin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. Argentina Biosimilar Insulin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Middle East and Africa Biosimilar Insulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Biosimilar Insulin Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Biosimilar Insulin Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Biosimilar Insulin Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Biosimilar Insulin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 79. Egypt Biosimilar Insulin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Turkey Biosimilar Insulin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. South Africa Biosimilar Insulin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Global Biosimilar Insulin Sales and Growth Rate (2021-2025) (K Pcs)
Figure 83. Global Biosimilar Insulin Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Biosimilar Insulin Market Forecast (2021-2025) (K Pcs)
Figure 85. Europe Sales Biosimilar Insulin Market Forecast (2021-2025) (K Pcs)
Figure 86. Asia-Pacific Sales Biosimilar Insulin Market Forecast (2021-2025) (K Pcs)
Figure 87. South America Sales Biosimilar Insulin Market Forecast (2021-2025) (K Pcs)
Figure 88. Middle East & Africa Sales Biosimilar Insulin Market Forecast (2021-2025) (K Pcs)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel